Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher Tells Investors to Reject Mini-Tender Offer

NEW YORK (GenomeWeb) – Thermo Fisher Scientific said after the close of the market on Tuesday that it has received notice that private investment firm TRC Capital has made an unsolicited mini-tender offer to purchase up to 1 million shares of the company's stock at $181.75 per share in cash.

Thermo Fisher is recommending its shareholders to reject the offer. The TRC offer price is about 4.43 percent lower than the $190.17 closing price of Thermo Fisher's shares on Nov. 17, the last closing price before the offer was made. The offer is for about .249 percent of Thermo's outstanding shares of common stock as of the offer date, it added.

Shares of Thermo Fisher closed on Tuesday up about 1 percent on the New York Stock Exchange at $192.93. The company had more than 400 million shares outstanding.

Mini-tender offers seek to acquire less than 5 percent of a firm's outstanding shares, avoiding some investor protections given to larger tender offers, Thermo Fisher said, adding that TRC has made "many similar unsolicited mini-tender offers" for other publicly traded companies.

According to Thermo Fisher, the US Securities and Exchange Commission has warned investors that some bidders make tenders at below-market prices "'hoping that they will catch investors off guard if the investor do not compare the offer price to the current market price." 

The Scan

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.

Using Bees to Gain Insights into Urban Microbiomes

As bees buzz around, they pick up debris that provides insight into the metagenome of their surroundings, researchers report in Environmental Microbiome.

Age, Genetic Risk Tied to Blood Lipid Changes in New Study

A study appearing in JAMA Network Open suggests strategies to address high lipid levels should focus on individuals with high genetic risk and at specific ages.

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.